Last checked at 
10 Jun 2016 13:25
RNS Number : 8974A
Intl. Biotechnology Trust PLC
10 June 2016
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 May 2016
Net Assets | £199m |
Net Assets per share | 519p |
Share price | 450p |
Total value of unquoted investments | £21m |
Total number of portfolio companies | 82 |
Top Ten Holdings
Company Name | % NAV |
Celgene | 7.6 |
Biogen | 6.9 |
Regeneron | 6.2 |
Genmab | 5.6 |
Alexion | 4.6 |
Amgen | 4.3 |
Ophthotech | 3.6 |
Vertex | 3.5 |
Biomarin | 3.4 |
Gilead | 3.1 |
----------- | |
Total | 48.8 |
Portfolio Revenue Split |
% NAV |
Revenue Generating | 75 |
Near Revenue | 3 |
No sales in the near term | 22 |
----------- | |
Total | 100 |
Geographical Allocation | % NAV |
US & Canada | 78 |
Europe & UK | 22 |
----------- | |
Total | 100 |
Quoted/Unquoted Allocation | % NAV |
Quoted | 90 |
Unquoted | 10 |
----------- | |
Total | 100 |
BNP Paribas Secretarial Services Limited
Company Secretary
10 JUNE 2016
This information is provided by RNS
The company news service from the London Stock Exchange